Brief: Calcimedica Announces FDA Clearance Of Ind Application For Phase 2 Trial Of Auxora™

Calcimedica

13/02/2024 15:21

Feb 13 (Reuters) - CalciMedica Inc  CALC.O :
    * CALCIMEDICA ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR
PHASE
2 TRIAL OF AUXORA™ FOR THE TREATMENT OF SEVERE ACUTE KIDNEY
INJURY
    * PHASE 2 TRIAL, EXPECTED TO BEGIN IN 1H 2024
    * EXPECTS TO INITIATE TRIAL, NAMED KOURAGE, IN FIRST HALF OF
2024
AND DATA EXPECTED IN 2025

Source text for Eikon:  ID:nPn6kT82La 
Further company coverage:  CALC.O 

 ((Reuters.Briefs@thomsonreuters.com;))